nintedanib
not tagged
['ninteda']
treating the underlying ctd is key to managing ild in combination with anti-fibrotic. in the sencis study, patients on combination of mmf at baseline +nintedanib had reduced decline in fvc compared to nintedanib alone paul noble #acr22 
MD PhD Consultant Rheumatologist &Physician,Assoc Medical Director,Digital Leader,NASS Trustee &Best Rheum Care,Visiting Fellow Henley Business School,ExecCoach